All the considered patient-derived cell lines were negative for the expression of angiogenic cell markers such as CD31 and CD36, which have been previously found also on glioma cancer stem cells (35, 38, 39, 46) (Figure 2). This evidence concerns the gene PECAM1 and central nervous system cancer.